Amantadine Hydrochloride NDC 71205-223

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-223Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0223Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71205-223-20	71205022320	20 CAPSULE in 1 BOTTLE (71205-223-20)Marketed from Feb 1, 2019
71205-223-30	71205022330	30 CAPSULE in 1 BOTTLE (71205-223-30)Marketed from Feb 1, 2019
71205-223-60	71205022360	60 CAPSULE in 1 BOTTLE (71205-223-60)Marketed from Feb 1, 2019
71205-223-90	71205022390	90 CAPSULE in 1 BOTTLE (71205-223-90)Marketed from Feb 1, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amantadine Hydrochloride
Generic name (nonproprietary): amantadine hydrochloride
Active ingredients: Amantadine hydrochloride — 100 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209047
Marketing start: Jun 30, 2016
Listing expires: Dec 31, 2026
Other FDA classes: M2 Protein Inhibitors (Mechanism)
Identifiers: Product ID 71205-223_600e1f99-3fda-4a12-8041-a4fc6dbced4eSPL ID 600e1f99-3fda-4a12-8041-a4fc6dbced4eSPL set ID f0e9b795-c0a1-4c95-928c-dacaaf9b3bb5RxCUI 849389UNII M6Q1EO9TD0
Pharmacologic class: Influenza A M2 Protein Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205022320 followed by a unit qualifier and the quantity

Package 71205-0223-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 1, 2019.

Indications (excerpt from the label)

INDICATIONS & USAGE Amantadine hydrochloride capsules are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Amantadine hydrochloride capsules are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. Influenza A Prophylaxis Amantadine hydrochloride capsules are indicated for chemoprophylaxis against signs and symptoms of influenza A virus infection. Because amantadine does not completely prevent the host immune response to influenza A infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later expo…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209047

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209047
Product	Strength	Form · route	Labeler	Product NDC
Amantadine HCL	Amantadine hydrochloride 100 mg/1	CapsuleOral	Direct_Rx	72189-412
Amantadine Hydrochloride	Amantadine hydrochloride 100 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-9618
Amantadine Hydrochloride	Amantadine hydrochloride 100 mg/1	CapsuleOral	Strides Pharma Inc.	42543-493